share_log
Reuters ·  Oct 31 01:30
HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in Fruzaqla® (Fruquintinib) Sales by Takeda
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment